Vitafoods Europe 2025 es el principal evento mundial de nutracéuticos, donde profesionales de la industria se reúnen para descubrir las últimas innovaciones, establecer nuevas asociaciones y conectar con líderes y expertos del sector. Detalles del evento: Fecha de inicio: 20 de mayo de 2025 Fecha de finalización: 22 de mayo de 2025 Ubicación: Fira Barcelona...
Visit us at booth #O41
SupplySide Global es el evento líder en innovación nutricional y ciencias de la salud. Reúne a investigadores, fabricantes, proveedores y emprendedores para explorar ingredientes funcionales, nutracéuticos, tendencias en formulación y regulaciones internacionales. Con sesiones técnicas, networking global y exhibiciones de vanguardia, SupplySide es el punto de encuentro esencial para quienes operan en el sector salud...
Cookies on this website are used to personalize content and advertisements, provide social media features, and analyze traffic. In addition, we share information about your use of the website with our social media, advertising and web analytics partners, who may combine it with other information that you have provided to them or that they have collected from your use of their services.If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission.We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience. Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement. You can find more information about the use of your data in our privacy policy. You can revoke or adjust your selection at any time under Settings.
| Category | Study Type | Study Findings | Reference | Link |
| Cardiovascular & Metabolic Health | Animal Study – Endothelial Function | Preserved endothelial function and lower oxidative markers in hypercholesterolemic pigs. | Rev Esp Cardiol. 2015;68(3):216–25. | https://doi.org/10.1016/j.rec.2014.04.021 |
| Animal Study – Fructose-Fed Rat Model | Lower fat accumulation, microbiota shifts, and urolithin-like metabolites in fructose-fed rats. | Food Funct. 2024;15:7348–7363. | https://doi.org/10.1039/d4fo00688g | |
| Clinical Study – Cardiometabolic Health | Lower systolic BP, reduced cortisol, and higher quality-of-life scores. | EC Nutr. 2015;2:396–411. | https://www.researchgate.net/publication/341119964 | |
| Clinical Study – Antioxidant Markers | Lower blood pressure and cortisol, higher antioxidant capacity, and urolithin A. | Antioxidants. 2022;11:2124. | https://doi.org/10.3390/antiox11112124 | |
| Clinical Study – Blood Pressure | Lower diastolic blood pressure after 8 weeks. | J Nutr Sci. 2017;6:e39. | https://doi.org/10.1017/jns.2017.36 | |
| Healthy Aging | In Vivo – Longevity & AHR Pathway | Extended lifespan in C. elegans; AHR pathway activation in mouse liver. | Int J Mol Sci. 2024;25:9943. | https://doi.org/10.3390/ijms25189943 |
| Animal Study – Oxidative Stress in Aging Mice | Reduced basal ROS, protected WBC from induced oxidative damage, improved redox balance. | Int J Mol Sci. 2025;26:5957. | https://doi.org/10.3390/ijms26135957 | |
| Clinical Study – IGF-1 & Telomere Biology | Moderate rise in circulating IGF-1; telomere length maintained over 12 weeks. | Nutrients. 2025;17:2974. | https://doi.org/10.3390/nu17182974 | |
| Sports Nutrition | Clinical Study – Endurance Performance | Improved time to exhaustion and post-exercise muscle recovery. | Nutrients. 2019;11:721. | https://doi.org/10.3390/nu11040721 |
| Cognition & Behaviour | Animal Study – Frailty Prevention | Improved coordination and neuromuscular function, with lower oxidative damage in aging mice. | Antioxidants. 2023;12:1991. | https://doi.org/10.3390/antiox12111991 |
| Clinical Study – Acute Cognitive Performance | Faster logical reasoning and improved working-memory performance. | Academic Press; 2021. Chapter 10. | https://doi.org/10.1016/B978-0-12-820593-8.00010-0 | |
| Clinical Study – Satiety & Eating Behaviour | Higher satiety ratings and reduced food intake during a test meal. | Foods. 2022;11:2639. | https://doi.org/10.3390/foods11172639 | |
| Healthy Inflammatory Response | In Vitro – Inflammasome Activation | Reduced IL-1β release in ATP-stimulated macrophages. | Cell Death Differ. 2016;23:1219–31. | https://doi.org/10.1038/cdd.2015.176 |
| In Vitro – Corneal Epithelium Model | Lower IL-8 release and higher cell viability in LPS-stimulated corneal epithelial cells. | J Clin Transl Ophthalmol. 2023;1:52–60. | https://doi.org/10.3390/jcto1020007 | |
| Animal Study – TNF-α–Induced Muscle Catabolism | Maintained muscle mass and reduced inflammatory signalling in TNF-α–challenged mice. | Mol Nutr Food Res. 2017;61:1600169. | https://doi.org/10.1002/mnfr.201600169 | |
| Clinical Study – Cytokines & Cardiometabolic Health | Lower IL-6 and IL-1β, with trends in CRP, TNF-α, and systolic BP. | Nutrients. 2025;17:1235. | https://doi.org/10.3390/nu17071235 | |
| Skin Health | In Vitro – Photoaging Effects | Reduced UV-induced ROS, enhanced collagen and HA metabolism, and tyrosinase inhibition. | Int J Food Sci Nutr. 2022;74:51–63. | https://doi.org/10.1080/09637486.2022.2152189 |
| Microbial Response | In Vitro – Antimicrobial Activity Assays | Bactericidal and antifungal effects against tested microorganisms. | Int J Mol Sci. 2024;25:6943. | https://doi.org/10.3390/ijms25136943 |
| Gut Health | In Vitro – Proof of Concept | Punicalagin converted into ellagic acid by selected probiotics (urolithin precursor formation). | J Agric Food Chem. 2022;70:16273–16285. | https://doi.org/10.1021/acs.jafc.2c06585 |
| Study Type | Key Findings | Reference |
|---|---|---|
| In-vivo Safety Study (Genotoxicity) | No mutation induced. Safe dose: 30mg/day or 2000mg/kg (single dose) | Mutation Research 777 (2015) |
| Subchronic Toxicity (13 weeks) | No toxicological effect up to 500mg/kg/day | Food Chem Toxicol 84 (2015) |
| Antimicrobial In-vitro Study | Antibacterial activity (E. coli, S. aureus) and antioxidant packaging effects | Foods 2020, 9, 1339 |
| Human Study (15mg/day, 3 weeks) | Improved body composition, antioxidant status, gene expression (inflammation/oxidative stress) | Oxid Med Cell Longev. 2017 |
| Antioxidant, CV Support (acute dose) | Strong antioxidant effect, reduced lipid peroxidation, SOD up-regulation | Biomedicine & Prevention 2017 |
| Breast Cancer Patients (adjunct to chemo) | Reduced TIMP-1 levels, potential for improved prognosis | Antioxidants 2019, 8, 393 |
| Exploratory Stroke Study (humans) | Reduced HbA1c, diastolic BP, improved neurological/functional outcomes | Int. J. Mol. Sci. 2024 |
